• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Mol Cell Biol . COVID-19 and cardiovascular diseases

tetano

Editor, Senior Moderator
J Mol Cell Biol


. 2020 Nov 23;mjaa064.
doi: 10.1093/jmcb/mjaa064. Online ahead of print.
COVID-19 and cardiovascular diseases


Fan Liu[SUP] 1 [/SUP], Feng Liu[SUP] 2 3 4 [/SUP], Lu Wang[SUP] 1 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), besides the lung, this infectious disease also has severe implications in cardiovascular system. In this review, we summarize diverse clinical complications of heart and vascular system, as well as the relevant high mortality, in COVID-19 patients. Systemic inflammation and angiotensin-converting enzyme 2-involved signaling networking in SARS-CoV-2 infection and cardiovascular system may contribute to the manifestations of cardiovascular diseases. Therefore, integration of clinical observations and experimental findings can promote our understanding of the underlying mechanisms, which would aid in identifying and treating the cardiovascular injury in patients with COVID-19 appropriately.

Keywords: ACE2; COVID-19; SARS-CoV-2; cardiovascular diseases; systemic inflammation.
 
Back
Top Bottom